Companies with normal risk readings
Companies with normal risk readings: 2,472 companies ranked by a composite risk reading built from filed statements -- leverage, cash conversion, operating pressure, customer and supplier concentration and competitive position. Recomputed 1 September 2026.
Composite readings for 8,308 companies, recomputed 1 September 2026. A company appears here once at least three weighted categories cleared their inputs; the rest carry per-mechanism readings without a headline.
| Company | Reading | Band | Sector | Country | Coverage | Market cap |
|---|---|---|---|---|---|---|
| NVIDIA Corp NVDA | 24 | Normal | Technology | United States | 5 / 6 | $5.3T |
| Alphabet Inc. GOOGL | 27 | Normal | Communication Services | United States | 5 / 6 | $4.2T |
| Microsoft Corporation MSFT | 24 | Normal | Technology | United States | 5 / 6 | $3.8T |
| Taiwan Semiconductor Manufacturing TSM | 22 | Normal | Technology | Taiwan | 5 / 6 | $2.2T |
| Broadcom Inc AVGO | 20 | Normal | Technology | United States | 4 / 6 | $1.8T |
| Micron Technology Inc MU | 35 | Normal | Technology | United States | 5 / 6 | $1.1T |
| Advanced Micro Devices Inc AMD | 34 | Normal | Technology | United States | 5 / 6 | $759.8B |
| ASML Holding N.V. ASME | 30 | Normal | Technology | Netherlands | 4 / 6 | $670.6B |
| ASML Holding NV ASML | 25 | Normal | Technology | Netherlands | 5 / 6 | $653.7B |
| Johnson & Johnson JNJ | 37 | Normal | Healthcare | United States | 4 / 6 | $645.5B |
| Coca-Cola Company KO | 30 | Normal | Consumer Defensive | United States | 4 / 6 | $385.8B |
| Lam Research Corp LRCX | 30 | Normal | Technology | United States | 5 / 6 | $377.8B |
| Roche Holding AG RO | 32 | Normal | Healthcare | Switzerland | 5 / 6 | $370.1B |
| Applied Materials Inc AMAT | 38 | Normal | Technology | United States | 5 / 6 | $366.4B |
| Merck & Co Inc MRK | 26 | Normal | Healthcare | United States | 5 / 6 | $366.2B |
| General Electric Company GE | 29 | Normal | Industrials | United States | 5 / 6 | $355.4B |
| Procter & Gamble Company PG | 34 | Normal | Consumer Defensive | United States | 5 / 6 | $334.1B |
| Kioxia Holdings Corporation KI5 | 25 | Normal | Technology | Japan | 4 / 6 | $321.1B |
| Palo Alto Networks Inc PANW | 28 | Normal | Technology | United States | 5 / 6 | $302.1B |
| Philip Morris International Inc PM | 24 | Normal | Consumer Defensive | United States | 4 / 6 | $299.1B |
| RTX Corp RTX | 38 | Normal | Industrials | United States | 5 / 6 | $285.3B |
| Novartis AG NVS | 25 | Normal | Healthcare | Switzerland | 5 / 6 | $281.6B |
| Sap SE SAP | 35 | Normal | Technology | Germany | 5 / 6 | $255.7B |
| Arm Holdings plc. ARM | 30 | Normal | Technology | United Kingdom | 5 / 6 | $255.3B |
| Astrazeneca plc AZN | 30 | Normal | Healthcare | United Kingdom | 5 / 6 | $252.3B |
| BHP Group Ltd BHP | 22 | Normal | Basic Materials | Australia | 5 / 6 | $241.7B |
| L'Oréal S.A. LOR | 32 | Normal | Consumer Defensive | France | 5 / 6 | $238.8B |
| AMGEN Inc AMGN | 33 | Normal | Healthcare | United States | 4 / 6 | $233.8B |
| KLA Corp KLAC | 31 | Normal | Technology | United States | 5 / 6 | $229.4B |
| Linde Plc. LIN | 36 | Normal | Basic Materials | United Kingdom | 4 / 6 | $225.7B |
| Sandisk Corp SNDK | 21 | Normal | Technology | United States | 4 / 6 | $216.8B |
| Industria De Diseno Textil SA IXD1 | 28 | Normal | Basic Materials | Spain | 4 / 6 | $210.0B |
| Salesforce Inc CRM | 35 | Normal | Technology | United States | 5 / 6 | $209.7B |
| Verizon Communications Inc VZ | 35 | Normal | Communication Services | United States | 4 / 6 | $208.2B |
| Novo Nordisk A/S NOVO-B | 23 | Normal | Healthcare | Denmark | 3 / 6 | $206.4B |
| Shopify Inc - Class A SHOP | 30 | Normal | Technology | Canada | 5 / 6 | $197.1B |
| T-Mobile US Inc TMUS | 38 | Normal | Communication Services | United States | 4 / 6 | $194.9B |
| Amphenol Corp - Class A APH | 27 | Normal | Technology | United States | 5 / 6 | $194.4B |
| Marvell Technology Inc MRVL | 28 | Normal | Technology | United States | 5 / 6 | $189.5B |
| Seagate Technology Holdings Plc STX | 23 | Normal | Technology | Singapore | 5 / 6 | $188.2B |
| McDonald`s Corp MCD | 31 | Normal | Consumer Cyclical | United States | 5 / 6 | $187.5B |
| Walt Disney Co (The) DIS | 38 | Normal | Communication Services | United States | 5 / 6 | $187.0B |
| Union Pacific Corp UNP | 35 | Normal | Industrials | United States | 5 / 6 | $182.6B |
| Gilead Sciences Inc GILD | 31 | Normal | Healthcare | United States | 4 / 6 | $180.8B |
| Analog Devices Inc ADI | 36 | Normal | Technology | United States | 4 / 6 | $175.3B |
| Qualcomm Inc QCOM | 37 | Normal | Technology | United States | 5 / 6 | $173.5B |
| NextEra Energy Inc NEE | 39 | Normal | Utilities | United States | 5 / 6 | $170.7B |
| Rolls-Royce Holdings PLC RRU | 25 | Normal | Industrials | United Kingdom | 5 / 6 | $167.9B |
| Western Digital Corp WDC | 24 | Normal | Technology | United States | 4 / 6 | $165.9B |
| Safran SA SAF | 32 | Normal | Industrials | France | 5 / 6 | $163.3B |
| Uber Technologies Inc UBER | 39 | Normal | Technology | United States | 5 / 6 | $160.8B |
| Conoco Phillips COP | 33 | Normal | Energy | United States | 4 / 6 | $156.6B |
| Eaton Corporation plc ETN | 35 | Normal | Industrials | Ireland | 5 / 6 | $156.4B |
| Booking Holdings Inc BKNG | 22 | Normal | Consumer Cyclical | United States | 4 / 6 | $155.9B |
| Anheuser-Busch InBev SA/NV BUD | 35 | Normal | Consumer Defensive | Belgium | 5 / 6 | $155.1B |
| Novo Nordisk NVO | 31 | Normal | Healthcare | Denmark | 5 / 6 | $152.6B |
| ServiceNow Inc NOW | 31 | Normal | Technology | United States | 5 / 6 | $149.6B |
| TJX Companies Inc TJX | 36 | Normal | Consumer Cyclical | United States | 5 / 6 | $149.3B |
| Vertex Pharmaceuticals Inc VRTX | 20 | Normal | Healthcare | United States | 4 / 6 | $137.2B |
| Fast Retailing Co., Ltd. 9983 | 29 | Normal | Consumer Cyclical | Japan | 5 / 6 | $136.9B |
| Bristol-Myers Squibb Company BMY | 32 | Normal | Healthcare | United States | 4 / 6 | $136.0B |
| Intuitive Surgical Inc ISRG | 30 | Normal | Healthcare | United States | 4 / 6 | $131.9B |
| Prologis Inc PLD | 28 | Normal | Real Estate | United States | 4 / 6 | $131.3B |
| Stryker Corp SYK | 38 | Normal | Healthcare | United States | 5 / 6 | $126.8B |
| Keyence Corporation 6861 | 32 | Normal | Technology | Japan | 4 / 6 | $126.0B |
| Chocoladefabriken Lindt & Spruengli AG N LISN | 38 | Normal | Consumer Defensive | Switzerland | 5 / 6 | $125.6B |
| Parker-Hannifin Corp PH | 35 | Normal | Industrials | United States | 5 / 6 | $125.4B |
| Fortinet Inc FTNT | 29 | Normal | Technology | United States | 5 / 6 | $121.8B |
| British American Tobacco Plc BTI | 36 | Normal | Consumer Defensive | United Kingdom | 5 / 6 | $121.3B |
| Adobe Inc ADBE | 28 | Normal | Technology | United States | 4 / 6 | $116.3B |
| Altria Group Inc MO | 32 | Normal | Consumer Defensive | United States | 4 / 6 | $114.6B |
| Automatic Data Processing Inc ADP | 34 | Normal | Technology | United States | 5 / 6 | $114.4B |
| Snowflake Inc - Class A SNOW | 38 | Normal | Technology | United States | 5 / 6 | $113.7B |
| Airbnb Inc - Class A ABNB | 21 | Normal | Consumer Cyclical | United States | 4 / 6 | $111.8B |
| Freeport-McMoRan Inc FCX | 38 | Normal | Basic Materials | United States | 5 / 6 | $109.8B |
| Sanofi SNY | 39 | Normal | Healthcare | France | 5 / 6 | $109.3B |
| Applovin Corp - Class A APP | 22 | Normal | Communication Services | United States | 5 / 6 | $106.5B |
| Howmet Aerospace Inc HWM | 28 | Normal | Industrials | United States | 5 / 6 | $105.9B |
| Atlas Copco AB Series A ATCO-A | 27 | Normal | Industrials | Sweden | 3 / 6 | $104.2B |
| Equinix Inc EQIX | 36 | Normal | Real Estate | United States | 5 / 6 | $103.1B |
| GSK Plc GSK | 32 | Normal | Healthcare | United Kingdom | 5 / 6 | $102.8B |
| General Dynamics Corp GD | 38 | Normal | Industrials | United States | 5 / 6 | $102.6B |
| DoorDash Inc - Class A DASH | 24 | Normal | Consumer Cyclical | United States | 5 / 6 | $102.6B |
| GSK plc GS71 | 35 | Normal | Healthcare | United Kingdom | 4 / 6 | $100.5B |
| MercadoLibre Inc MELI | 29 | Normal | Consumer Cyclical | Uruguay | 5 / 6 | $99.7B |
| Vertiv Holdings Co - Class A VRT | 26 | Normal | Industrials | United States | 5 / 6 | $99.0B |
| Trane Technologies plc - Class A TT | 34 | Normal | Industrials | Ireland | 5 / 6 | $98.9B |
| Intuit Inc INTU | 32 | Normal | Technology | United States | 5 / 6 | $97.9B |
| CSX Corp CSX | 38 | Normal | Industrials | United States | 4 / 6 | $95.0B |
| Prosus N.V 1TY | 34 | Normal | Consumer Cyclical | Netherlands | 5 / 6 | $92.4B |
| Marriott International Inc - Class A MAR | 37 | Normal | Consumer Cyclical | United States | 5 / 6 | $91.9B |
| Monster Beverage Corp MNST | 29 | Normal | Consumer Defensive | United States | 4 / 6 | $91.8B |
| Quanta Services Inc PWR | 39 | Normal | Industrials | United States | 5 / 6 | $90.6B |
| Atlas Copco AB Series B ATCO-B | 27 | Normal | Industrials | Sweden | 3 / 6 | $88.5B |
| Waste Management Inc WM | 31 | Normal | Industrials | United States | 4 / 6 | $87.9B |
| Emerson Electric Company EMR | 34 | Normal | Industrials | United States | 5 / 6 | $86.6B |
| SLB SLB | 37 | Normal | Energy | United States | 5 / 6 | $85.1B |
| Datadog Inc - Class A DDOG | 38 | Normal | Technology | United States | 5 / 6 | $85.1B |
| Canadian Pacific Kansas City Ltd CP | 25 | Normal | Industrials | Canada | 5 / 6 | $83.0B |
| Regeneron Pharmaceuticals Inc REGN | 35 | Normal | Healthcare | United States | 5 / 6 | $82.1B |
By sector
Industrials 1,536Technology 1,292Healthcare 1,214Consumer Cyclical 1,116Basic Materials 577Communication Services 565Real Estate 552Consumer Defensive 536Energy 356Utilities 232
How the reading is built
Each company is scored on six mechanisms -- market expectation, operating pressure, cash conversion, leverage, concentration and competitive position -- from its own filed statements. A mechanism whose inputs do not clear its coverage floor is left unread rather than scored zero, and a reading built on thin coverage is pulled toward a neutral prior rather than claiming safety from what nobody looked at.
Descriptive, not advisory. These bands describe measured mechanisms; they are not investment advice, not a forecast, and not a statement about whether a share is worth owning.